Treace Medical Concepts (TMCI) Accounts Payables (2020 - 2026)

Treace Medical Concepts' Accounts Payables history runs 7 years deep, the most recent figure standing at $13.5 million for Q1 2026.

• Quarterly Accounts Payables rose 2.37% year-over-year to $13.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.5 million (up 2.37% YoY) and the FY2025 annual result came in at $6.7 million, down 36.08% from the prior year.
• Accounts Payables was $13.5 million for Q1 2026 at Treace Medical Concepts, up from $6.7 million in the prior quarter.
• Across five years, Accounts Payables topped out at $21.1 million in Q1 2024 and bottomed at $3.1 million in Q2 2022.
• A 5-year average of $11.5 million and a median of $10.5 million in 2024 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2024 — Accounts Payables jumped 316.65% — and 2025, when it sank 37.48%.
• Treace Medical Concepts' Accounts Payables stood at $8.7 million in 2022, then surged by 36.54% to $11.8 million in 2023, then declined by 11.09% to $10.5 million in 2024, then slumped by 36.08% to $6.7 million in 2025, then surged by 101.26% to $13.5 million in 2026.
• Business Quant data shows TMCI's Accounts Payables at $13.5 million in Q1 2026, $6.7 million in Q4 2025, and $16.1 million in Q3 2025.